Login / Signup

D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis.

Luis Jara PalomaresAurora Solier-LopezTeresa Elias-HernandezMaria Isabel Asensio-CruzIsabel Blasco-EsquiviasVeronica Sanchez-LopezMaria Rodriguez de la BorbollaElena Arellano-OrdenLionel Suarez-ValdiviaSamira Marin-RomeroLucia Marin-BarreraAranzazu Ruiz-GarciaEmilio Montero-RomeroSilvia Navarro-HerreroJose Luis Lopez-CamposMaria Pilar Serrano-GotarredonaJuan Manuel Praena-FernandezJose Maria Sanchez-DiazRemedios Otero-Candelera
Published in: British journal of cancer (2018)
This study identified that hs-CRP and DD were potential biomarkers of VTE recurrence after discontinuation of anticoagulation in CAT. A risk-adapted strategy could identify low-risk patients who may benefit from discontinuation of anticoagulation.
Keyphrases
  • venous thromboembolism
  • direct oral anticoagulants
  • atrial fibrillation
  • pulmonary embolism